{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:56:55Z","timestamp":1765040215680},"reference-count":54,"publisher":"Biomedical Research Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2009]]},"DOI":"10.2220\/biomedres.30.79","type":"journal-article","created":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T05:51:28Z","timestamp":1241157088000},"page":"79-86","source":"Crossref","is-referenced-by-count":10,"title":["Expression of syndecan-1 and E-cadherin is inversely correlated with poor patient's prognosis and recurrent status of extrahepatic bile duct carcinoma"],"prefix":"10.2220","volume":"30","author":[{"given":"Motonari","family":"Ohashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Kusumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harue","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Toyoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Hakamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1059","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Anttonen A, Heikkil&auml; P, Kajanti M, Jalkanen M and Joensuu H (2001) High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery. Lung Cancer 32, 297-305.","DOI":"10.1016\/S0169-5002(00)00230-0"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690088"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270412"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, Galligioni E and Doglioni C (2003) High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer 98, 474-483.","DOI":"10.1002\/cncr.11515"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bayer-Garner IB and Smoller BR (2001) The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma. J Cutan Pathol 28, 83-89.","DOI":"10.1034\/j.1600-0560.2001.280204.x"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-2-3"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cb.08.110192.002053"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Carey DJ (1997) Syndecans: multifunctional cell-surface coreceptors. Biochem J 327, 1-16.","DOI":"10.1042\/bj3270001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chen D, Adenekan B, Chen L, Vaughan ED, Gerald W, Feng Z and Knudsen BS (2004) Syndecan-1 expression in locally invasive and metastatic prostate cancer. Urology 63, 402-407.","DOI":"10.1016\/j.urology.2003.08.036"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Chu YQ, Ye ZY, Tao HQ, Wang YY and Zhao ZS (2008) Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma. World J Gastroenterol 14, 1990-1996.","DOI":"10.3748\/wjg.14.1990"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20001001)88:1<12::AID-IJC3>3.0.CO;2-T"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. David G (1993) Integral membrane heparan sulfate proteoglycans. FASEB J 7, 1023-1030.","DOI":"10.1096\/fasebj.7.11.8370471"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Day RM, Hao X, Ilyas M, Daszak P, Talbot IC and Forbes A (1999) Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence. Virchows Arch 434, 121-125.","DOI":"10.1007\/s004280050315"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ and Schulick RD (2007) Cholangiocarcinoma; Thirty-one-year experience with 564 patients at a single institution. Ann Surg 245, 755-762.","DOI":"10.1097\/01.sla.0000251366.62632.d3"},{"issue":"10","key":"15","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1349-7006.2001.tb01062.x","volume":"92","author":"FUJIYA M","year":"2001","ISSN":"http:\/\/id.crossref.org\/issn\/0910-5050","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG and Morrow M (2002) American Joint Committee on Cancer Staging Manual, 6th ed. Springer-Verlag, Tokyo.","DOI":"10.1007\/978-1-4757-3656-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Harada K, Masuda S, Hirano M and Nakanuma Y (2003) Reduced expression of syndecan-1 correlates with histologic dedifferentiation, lymph node metastasis, and poor prognosis in intrahepatic cholangiocarcinoma. Hum Pathol 34, 857-863.","DOI":"10.1016\/S0046-8177(03)00336-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hasengaowa, Kodama J, Kusumoto T, Shinyo Y, Seki N and Hiramatsu Y (2005) Prognostic significance of syndecan-1 expression in human endometrial cancer. Ann Oncol 16, 1109-1115.","DOI":"10.1093\/annonc\/mdi224"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hirohashi S (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153, 333-339.","DOI":"10.1016\/S0002-9440(10)65575-7"},{"key":"20","unstructured":"20. http:\/\/ganjoho.ncc.go.jp\/professional\/statistics\/statistics.html (accessed 4 June 2008) Vital Statistics of Japan, Ministry of Health, Labour & Welfare"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ilyas M and Tomlinson IP (1997) The interactions of APC, E-cadherin and beta-catenin in tumor development and progression. J Pathol 182, 128-137.","DOI":"10.1002\/(SICI)1096-9896(199706)182:2<128::AID-PATH839>3.0.CO;2-Q"},{"issue":"2","key":"22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/bjc.1994.300","volume":"70","year":"1994","ISSN":"http:\/\/id.crossref.org\/issn\/0007-0920","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Inki P, Stenb&auml;ck F, Grenman S and Jalkanen M (1994) Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J Pathol 172, 349-355.","DOI":"10.1002\/path.1711720410"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ishihara S, Miyakawa S, Takada T, Takasaki K, Nimura Y, Tanaka M, Miyazaki M, Nagakawa T, Kayahara M and Horiguchi A (2007) Status of surgical treatment of biliary tract cancer. Dig Surg 24, 131-136.","DOI":"10.1159\/000101901"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ito Y, Yoshida H, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kuma K and Miyauchi A (2003) Syndecan-1 expression in thyroid carcinoma: stromal expression followed by epithelial expression is significantly correlated with dedifferentiation. Histopathology 43, 157-164.","DOI":"10.1046\/j.1365-2559.2003.01656.x"},{"key":"26","unstructured":"26. Japanese Society of Biliary Surgery (2001) Classification of Biliary Tract Carcinoma. Kanehira & Co., Ltd., Tokyo."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Juuti A, Nordling S, Lundin J, Louhimo Jand Haglund C (2005) Syndecan-1 expression&mdash;a novel prognostic marker in pancreatic cancer. Oncology 68, 97-106.","DOI":"10.1159\/000085702"},{"issue":"5","key":"28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1091\/mbc.6.5.559","volume":"6","year":"1995","ISSN":"http:\/\/id.crossref.org\/issn\/1059-1524","issn-type":"print"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kemler R (1993) From cadherins to catenins: cytoplasmic protein interaction and regulation of cell adhesion. Trend Genet 9, 317-321.","DOI":"10.1016\/0168-9525(93)90250-L"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kim CW, Goldberger OA, Gallo RL and Bernfield M (1994) Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell 15, 797-805.","DOI":"10.1091\/mbc.5.7.797"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-007-1279-5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Takamori K, Igawa K, Yoshida M, Fukuyama H, Takahashi T and Sakoda S (2006) Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma. J Oral Pathol Med 35, 301-306.","DOI":"10.1111\/j.1600-0714.2006.00412.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Leivonen M, Lundin J, Nordling S, von Boguslawski K and Haglund C (2004) Prognostic value of syndecan-1 expression in breast cancer. Oncology 67, 11-18.","DOI":"10.1159\/000080280"},{"issue":"6","key":"34","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1242\/jcs.109.6.1393","volume":"109","year":"1996","ISSN":"http:\/\/id.crossref.org\/issn\/0021-9533","issn-type":"print"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Li HG, Xie DR, Shen XM, Li HH, Zeng H and Zeng YJ (2005) Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J Gastroenterol 11, 1445-1451.","DOI":"10.3748\/wjg.v11.i10.1445"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Loussouarn D, Campion L, Sagan C, Frenel JS, Dravet F, Classe JM, Pioud-Martigny R, Berton-Rigaud D, Bourbouloux E, Mosnier JF, Bataille FR and Campone M (2008) Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas. Br J Cancer 98, 1993-1998.","DOI":"10.1038\/sj.bjc.6604400"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.09.001"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<482::AID-IJC2>3.0.CO;2-#"},{"issue":"10","key":"39","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1349-7006.2001.tb01061.x","volume":"92","author":"MIKAMI S","year":"2001","ISSN":"http:\/\/id.crossref.org\/issn\/0910-5050","issn-type":"print"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Mikami T, Saegusa M, Mitomi H, Yanagisawa N, Ichinoe M and Okayasu I (2001) Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas. Am J Clin Pathol 116, 369-376.","DOI":"10.1309\/VV6D-3GAH-VEJM-DUJT"},{"key":"41","unstructured":"41. Mitselou A, Ioachim E, Peschos D, Charalabopoulos K, Michael M, Agnantis NJ and Vougiouklakis T (2007) Ecadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies. Exp Oncol 29, 54-60."},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.0.CO;2-A"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1007\/s005340200076"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Pignatelli M and Vessey CJ (1994) Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol 25, 849-856","DOI":"10.1016\/0046-8177(94)90002-7"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Pulkkinen JO, Penttinen M, Jalkanen M, Klemi P and Gr&eacute;nman R (1997) Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol 117, 312-315.","DOI":"10.3109\/00016489709117794"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Sasaki R, Takahashi M, Funato O, Nitta H, Murakami M, Kawamura H, Suto T, Kanno S and Saito K (2001) Prognostic significance of lymph node involvement in middle and distal bile duct cancer. Surgery 129, 677-683.","DOI":"10.1067\/msy.2001.114555"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Seyama Y and Makuuchi M (2007) Current surgical treatment for bile duct cancer. World J Gastroenterol 13, 1505-1515.","DOI":"10.3748\/wjg.v13.i10.1505"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Shariat SF, Svatek RS, Kabbani W, Walz J, Lotan Y, Karakiewicz PI and Roehrborn CG (2008) Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy. BJU Int 101, 232-237.","DOI":"10.1111\/j.1464-410X.2007.07181.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Shinyo Y, Kodama J, Hasengaowa, Kusumoto T and Hiramatsu Y (2005) Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer. Gynecol Oncol 96, 776-783.","DOI":"10.1016\/j.ygyno.2004.11.004"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Soukka T, Pohjola J, Inki P and Happonen RP (2000) Reduction of syndecan-1 expression is associated with dysplastic oral epithelium. J Oral Pathol Med 29, 308-313.","DOI":"10.1034\/j.1600-0714.2000.290704.x"},{"key":"51","unstructured":"51. Sun D, Mcalmon KR, Davies JA, Bernfield M and Hay ED (1998) Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. Int J Dev Biol 42, 733-736."},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1126\/science.2006419"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01513.x"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Zimmermann P and David G (1999) The syndecans, tuners of transmembrane signaling. FASEB J 13 Suppl:S91-S100.","DOI":"10.1096\/fasebj.13.9001.s91"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T01:39:26Z","timestamp":1710293966000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/biomedres\/30\/2\/30_2_79\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.30.79","relation":{},"ISSN":["1880-313X","0388-6107"],"issn-type":[{"value":"1880-313X","type":"electronic"},{"value":"0388-6107","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}